The Prognostic Importance of E-cadherin and p53 Gene Expression in Transitional Bladder Carcinoma Patients

Cancer Statistics, 2001

Robert T. Greenlee, M. B. Hill-Harmon, Thomas S. Murray et al. · CA A Cancer Journal for Clinicians · 2001 · 3.3K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Two molecular pathways to transitional cell carcinoma of the bladder.

Charles Spruck, Petra F. Ohneseit, Mirella Gonzalez‐Zulueta et al. · PubMed · 1994 · 606 citations

Medicine, Genetics, Oncology +12

Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease Progression

A. S. Sarkis, Guido Dalbagni, C. Cordon‐Cardo et al. · JNCI Journal of the National Cancer Institute · 1993 · 536 citations

Medicine, Oncology, Pathology +15

p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.

David Esrig, Charles Spruck, Peter W. Nichols et al. · PubMed · 1993 · 459 citations

Medicine, Molecular Biology, Oncology +12

Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors.

P P Bringuier, Rainy Umbas, H. Ewout Schaafsma et al. · PubMed · 1993 · 358 citations

Medicine, Oncology, Pathology +10